Literature DB >> 26994910

Erratum to: Pharmacokinetic evaluation of nanoparticle albumin-bound paclitaxel delivered via hepatic arterial infusion in patients with predominantly hepatic metastases.

Siqing Fu1, Kirk S Culotta2, Gerald S Falchook3, David S Hong3, Alan L Myers4, Yan-Ping Zhang4, Aung Naing3, Filip Janku3, Ming-Mo Hou3,5, Razelle Kurzrock6.   

Abstract

In the original article, corresponding author's given name and family name are flipped. It should be "Siqing Fu" rather than "Fu Siqing".

Entities:  

Year:  2016        PMID: 26994910     DOI: 10.1007/s00280-016-3002-1

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  1 in total

Review 1.  Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors.

Authors:  Bilal Zulfiqar; Amnah Mahroo; Kaenat Nasir; Rai Khalid Farooq; Nasir Jalal; Muhammad Usman Rashid; Kashif Asghar
Journal:  Onco Targets Ther       Date:  2017-01-21       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.